Iona Walton
Denosumab may be more effective than risedronate for bone mineral density
Denosumab was superior to risedronate for increasing spine and hip bone mineral density in people receiving glucocorticoids according to a team from the University of Alabama in the US. And both treatments had a similar safety profile. Continue reading
Filgotinib seems to be effective in people with psoriatic arthritis says new research
Filgotinib, an oral selective JAK1 inhibitor currently under investigation for the treatment of rheumatoid arthritis and Crohn’s disease may also be of interest to those with psoriatic arthritis according to research presented at the American College of Rheumatology Annual Meeting. Continue reading
Pain sensitisation increases the risk of knee pain not going away
Pain sensitisation – or becoming more sensitive to pain – is an important risk factor for developing persistent knee pain in osteoarthritis, according to a new study in Arthritis & Rheumatology. Continue reading
Building quad strength improves function in women with osteoarthritis
Modest improvements in quadricep strength are linked to better performance in chair-stand tests in women – but not men – who have (or are at risk for) knee osteoarthritis says a study in Arthritis Care & Research. Continue reading
Text message reminders improve methotrexate adherence in people with rheumatoid arthritis
Weekly text message reminders have a positive impact on methotrexate adherence in adults with rheumatoid arthritis, researchers outline in Arthritis Care & Research. Continue reading
